| Product | Code | ||
|---|---|---|---|
| CD272 Polyclonal Antibody | AP68926 | 100 µl |
Contact us |
| CD284 Polyclonal Antibody | AP68927 | 100 µl |
Contact us |
| CD298 Polyclonal Antibody | AP68928 | 100 µl |
Contact us |
| CD2BP2 Polyclonal Antibody | AP68929 | 100 µl |
Contact us |
| CD300f Polyclonal Antibody | AP68931 | 100 µl |
Contact us |
| CD31 Polyclonal Antibody | AP68935 | 100 µl |
Contact us |
| CD314 Polyclonal Antibody | AP68936 | 100 µl |
Contact us |
| CD32 Polyclonal Antibody | AP68937 | 100 µl |
Contact us |
| CD32-A Polyclonal Antibody | AP68938 | 100 µl |
Contact us |
| CD34 Polyclonal Antibody | AP68940 | 100 µl |
Contact us |
| CD3EAP Polyclonal Antibody | AP68942 | 100 µl |
Contact us |
| CD3-δ Polyclonal Antibody | AP68943 | 100 µl |
Contact us |
Abcepta
Abcepta is a leading manufacturer of primary antibodies with more than fifteen years of experience. We supply quality antibodies and related products drug discovery and academic laboratories worldwide. Our focus is on targets covering the major research areas impacting health and disease, including cancer, metabolism, cardiovascular, neuroscience, and stem cells.
More information?Contact Us by e-mail info@divbio.eu
Affinity Biotech
Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development.
Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe.Our customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline our commitment to our customers and enhance our standards of service, we have opened packaging and quality control facilities in the People’s Republic of China. Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.
Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe.Our customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline our commitment to our customers and enhance our standards of service, we have opened packaging and quality control facilities in the People’s Republic of China. Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.
The prices are on request! Contact Us by e-mail info@divbio.co.za